{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,5]],"date-time":"2026-06-05T04:10:15Z","timestamp":1780632615953,"version":"3.54.1"},"reference-count":23,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2005,7,29]],"date-time":"2005-07-29T00:00:00Z","timestamp":1122595200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Support Care Cancer"],"published-print":{"date-parts":[[2006,3]]},"DOI":"10.1007\/s00520-005-0875-7","type":"journal-article","created":{"date-parts":[[2005,7,28]],"date-time":"2005-07-28T12:55:10Z","timestamp":1122555310000},"page":"268-276","source":"Crossref","is-referenced-by-count":28,"title":["A pilot study of ondansetron plus metopimazine vs. ondansetron monotherapy in children receiving highly emetogenic chemotherapy: a Bayesian randomized serial N-of-1 trials design"],"prefix":"10.1007","volume":"14","author":[{"given":"P. C.","family":"Nathan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G.","family":"Tomlinson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L. L.","family":"Dupuis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M. L.","family":"Greenberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Ota","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"U.","family":"Bartels","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B. M.","family":"Feldman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2005,7,29]]},"reference":[{"key":"875_CR1","doi-asserted-by":"crossref","first-page":"777","DOI":"10.2165\/00003495-200464070-00013","volume":"64","author":"TM Dando","year":"2004","unstructured":"Dando TM, Perry CM (2004) Aprepitant: a review of its use in the prevention of chemotherapy-induced nausea and vomiting. Drugs 64:777\u2013794","journal-title":"Drugs"},{"key":"875_CR2","first-page":"683","volume":"37","author":"H Debray","year":"1990","unstructured":"Debray H, Guihard J, Peyramond D, Tron P (1990) Treatment of vomiting in infants and children induced by acute infectious pathology. A comparative study of alizapride versus metopimazine. Ann Pediatr (Paris) 37:683\u2013687","journal-title":"Ann Pediatr (Paris)"},{"key":"875_CR3","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1007\/BF00686291","volume":"30","author":"MG Donelli","year":"1992","unstructured":"Donelli MG, Zucchetti M, D\u2019Incalci M (1992) Do anticancer agents reach the tumor target in the human brain? Cancer Chemother Pharmacol 30:251\u2013260","journal-title":"Cancer Chemother Pharmacol"},{"key":"875_CR4","doi-asserted-by":"crossref","first-page":"597","DOI":"10.2165\/00148581-200305090-00003","volume":"5","author":"LL Dupuis","year":"2003","unstructured":"Dupuis LL, Nathan PC (2003) Options for the prevention and management of acute chemotherapy-induced nausea and vomiting in children. Paediatr Drugs 5:597\u2013613","journal-title":"Paediatr Drugs"},{"key":"875_CR5","doi-asserted-by":"crossref","first-page":"2971","DOI":"10.1200\/JCO.1999.17.9.2971","volume":"17","author":"RJ Gralla","year":"1999","unstructured":"Gralla RJ, Osoba D, Kris MG, Kirkbride P, Hesketh PJ, Chinnery LW, Clark-Snow R, Gill DP, Groshen S, Grunberg S, Koeller JM, Morrow GR, Perez EA, Silber JH, Pfister DG (1999) Recommendations for the use of antiemetics: evidence-based, clinical practice guidelines. American Society of Clinical Oncology. J Clin Oncol 17:2971\u20132994","journal-title":"J Clin Oncol"},{"key":"875_CR6","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1007\/s00520-004-0756-5","volume":"13","author":"RJ Gralla","year":"2005","unstructured":"Gralla RJ, Roila F, Tonato M (2005) The 2004 Perugia Antiemetic Consensus Guideline process: methods, procedures, and participants. Support Care Cancer 13:77\u201379","journal-title":"Support Care Cancer"},{"key":"875_CR7","first-page":"5","volume":"24","author":"M Grant","year":"1997","unstructured":"Grant M (1997) Nausea and vomiting, quality of life, and the oncology nurse. Oncol Nurs Forum 24:5\u20137","journal-title":"Oncol Nurs Forum"},{"key":"875_CR8","doi-asserted-by":"crossref","first-page":"1076","DOI":"10.1056\/NEJM199304153281502","volume":"328","author":"J Herrstedt","year":"1993","unstructured":"Herrstedt J, Sigsgaard T, Boesgaard M, Jensen TP, Dombernowsky P (1993) Ondansetron plus metopimazine compared with ondansetron alone in patients receiving moderately emetogenic chemotherapy. N Engl J Med 328:1076\u20131080","journal-title":"N Engl J Med"},{"key":"875_CR9","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1007\/BF01681960","volume":"5","author":"J Herrstedt","year":"1997","unstructured":"Herrstedt J, Sigsgaard T, Angelo HR, Kampmann JP, Hansen M (1997) Dose-finding study of oral metopimazine. Support Care Cancer 5:38\u201343","journal-title":"Support Care Cancer"},{"key":"875_CR10","doi-asserted-by":"crossref","first-page":"1690","DOI":"10.1200\/JCO.1997.15.4.1690","volume":"15","author":"J Herrstedt","year":"1997","unstructured":"Herrstedt J, Sigsgaard T, Handberg J, Schousboe BM, Hansen M, Dombernowsky P (1997) Randomized, double-blind comparison of ondansetron versus ondansetron plus metopimazine as antiemetic prophylaxis during platinum-based chemotherapy in patients with cancer. J Clin Oncol 15:1690\u20131696","journal-title":"J Clin Oncol"},{"key":"875_CR11","first-page":"412","volume":"45","author":"J Herrstedt","year":"1998","unstructured":"Herrstedt J (1998) Chemotherapy-induced nausea and vomiting with special emphasis on metopimazine. Dan Med Bull 45:412\u2013422","journal-title":"Dan Med Bull"},{"key":"875_CR12","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1634\/theoncologist.4-3-191","volume":"4","author":"PJ Hesketh","year":"1999","unstructured":"Hesketh PJ (1999) Defining the emetogenicity of cancer chemotherapy regimens: relevance to clinical practice. Oncologist 4:191\u2013196","journal-title":"Oncologist"},{"key":"875_CR13","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1136\/bmj.303.6795.173","volume":"303","author":"T Johannessen","year":"1991","unstructured":"Johannessen T (1991) Controlled trials in single subjects. 1. Value in clinical medicine. BMJ 303:173\u2013174","journal-title":"BMJ"},{"key":"875_CR14","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1093\/jac\/11.3.245","volume":"11","author":"H Kourtopoulos","year":"1983","unstructured":"Kourtopoulos H, Holm SE, Norrby SR (1983) The influence of steroids on the penetration of antibiotics into brain tissue and brain abscesses. An experimental study in rats. J Antimicrob Chemother 11:245\u2013249","journal-title":"J Antimicrob Chemother"},{"key":"875_CR15","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1023\/A:1008276412559","volume":"8","author":"B Lebeau","year":"1997","unstructured":"Lebeau B, Depierre A, Giovannini M, Riviere A, Kaluzinski L, Votan B, Hedouin M, d\u2019Allens H (1997) The efficacy of a combination of ondansetron, methylprednisolone and metopimazine in patients previously uncontrolled with a dual antiemetic treatment in cisplatin-based chemotherapy. The French Ondansetron Study Group. Ann Oncol 8:887\u2013892","journal-title":"Ann Oncol"},{"key":"875_CR16","doi-asserted-by":"crossref","first-page":"1328","DOI":"10.1016\/S0196-0644(05)80119-2","volume":"22","author":"RJ Lewis","year":"1993","unstructured":"Lewis RJ, Wears RL (1993) An introduction to the Bayesian analysis of clinical trials. Ann Emerg Med 22:1328\u20131336","journal-title":"Ann Emerg Med"},{"key":"875_CR17","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1159\/000227647","volume":"53","author":"D Osoba","year":"1996","unstructured":"Osoba D, Zee B, Warr D, Kaizer L, Latreille J, Pater J (1996) Quality of life studies in chemotherapy-induced emesis. Oncology 53:92\u201395","journal-title":"Oncology"},{"key":"875_CR18","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1007\/s005200050156","volume":"6","author":"F Roila","year":"1998","unstructured":"Roila F, Aapro M, Stewart A (1998) Optimal selection of antiemetics in children receiving cancer chemotherapy. Support Care Cancer 6:215\u2013220","journal-title":"Support Care Cancer"},{"key":"875_CR19","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1007\/s005200100295","volume":"10","author":"F Roila","year":"2002","unstructured":"Roila F, Donati D, Tamberi S, Margutti G (2002) Delayed emesis: incidence, pattern, prognostic factors and optimal treatment. Support Care Cancer 10:88\u201395","journal-title":"Support Care Cancer"},{"key":"875_CR20","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1016\/S0022-510X(96)00206-7","volume":"144","author":"IJ Schatz","year":"1996","unstructured":"Schatz IJ, Bannister R, Freeman RL, Goetz CG, Jankovic J, Kaufman HC, Koller WC, Low PA, Mathias CJ, Polinsky RJ, Quinn NP, Robertson D, Streeten DHP (1996) Consensus statement on the definition of orthostatic hypotension, pure autonomic failure, and multiple system atrophy. J Neurol Sci 144:218\u2013219","journal-title":"J Neurol Sci"},{"key":"875_CR21","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1023\/A:1005835212246","volume":"37","author":"CS Straathof","year":"1998","unstructured":"Straathof CS, van den Bent MJ, Ma J, Schmitz PI, Kros JM, Stoter G, Vecht CJ, Schellens JH (1998) The effect of dexamethasone on the uptake of cisplatin in 9L glioma and the area of brain around tumor. J Neuro-Oncol 37:1\u20138","journal-title":"J Neuro-Oncol"},{"key":"875_CR22","doi-asserted-by":"crossref","first-page":"1704","DOI":"10.1212\/WNL.48.6.1704","volume":"48","author":"M Weller","year":"1997","unstructured":"Weller M, Schmidt C, Roth W, Dichgans J (1997) Chemotherapy of human malignant glioma: prevention of efficacy by dexamethasone? Neurology 48:1704\u20131709","journal-title":"Neurology"},{"key":"875_CR23","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1016\/S0895-4356(96)00429-5","volume":"50","author":"DR Zucker","year":"1997","unstructured":"Zucker DR, Schmid CH, McIntosh MW, D\u2019Agostino RB, Selker HP, Lau J (1997) Combining single patient (N-of-1) trials to estimate population treatment effects and to evaluate individual patient responses to treatment. J Clin Epidemiol 50:401\u2013410","journal-title":"J Clin Epidemiol"}],"container-title":["Supportive Care in Cancer"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00520-005-0875-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00520-005-0875-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00520-005-0875-7","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,4,8]],"date-time":"2020-04-08T11:32:15Z","timestamp":1586345535000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00520-005-0875-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,7,29]]},"references-count":23,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2006,3]]}},"alternative-id":["875"],"URL":"https:\/\/doi.org\/10.1007\/s00520-005-0875-7","relation":{},"ISSN":["0941-4355","1433-7339"],"issn-type":[{"value":"0941-4355","type":"print"},{"value":"1433-7339","type":"electronic"}],"subject":[],"published":{"date-parts":[[2005,7,29]]}}}